TotalMarketCap

Belite Bio

BLTENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.756 B

$142.93 -7.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Belite Bio (BLTE) has a market capitalization of $5.76B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$77.6M

Loss-making

Shares outstanding

39,339,960

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #49Ligand PharmaceuticalsLGND$5.95B
  2. #50GrifolsGRFS$5.85B
  3. #51Belite BioBLTE$5.76B
  4. #52Ptc TherapeuticsPTCT$5.48B
  5. #53VeradermicsMANE$5.38B

What if Belite Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$701,151.49

Per share 4,906× higher

Bitcoin $1.53T

$37,938.09

Per share 265× higher

Apple $5.02T

$124,547.20

Per share 871× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Belite Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.